In 10 seconds? Scientists have finally figured out how to tackle the KRas protein that is involved in promoting cancer. But much more work needs to be done before patients will broadly benefit.
What's the story? Mutations in the KRas protein (involved in cell growth, maturation, and death) are known to drive growth in many types of cancers, but scientists had deemed KRas ‘undruggable’. Finally, the tide is changing.